<DOC>
	<DOCNO>NCT01172626</DOCNO>
	<brief_summary>The purpose study investigate relationship side effect valproate sodium treatment epilepsy Han Chinese genetic polymorphism drug metabolize enzyme pharmacokinetics valproate sodium .</brief_summary>
	<brief_title>Exploration Genotype Based Personalized Prescription Valproate Sodium Anti-epileptic Treatment</brief_title>
	<detailed_description>Valproate sodium widely apply agent treatment epilepsy . Although Valproate sodium effective clinic , able induce several side effect , include weight gain , thin hair , loss appetite , nausea , vomit , hepatotoxicity , hematotoxicity , thrill , etc . However , remarkable variability reaction drug -- incidence side effect outcome treatment -- observe among patient . Valproate sodium metabolize enzymes liver transform several unreactive chemical excretion . Among two toxic metabolite catalyze specific metabolic enzyme . This study design explore genetic variation among individual key process deactivation elimination Valproate sodium order find whether genetic factor associate side effect efficacy . The understanding factor concern drug might imply possible solution minimize incidence side effect epileptic patient .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>The patient must diagnose epilepsy accord The International League Against Epilepsy ( ILAE ) criterion publish 2001 . The patient must sign informed consent . And patient 18 year old , signatures legal guardian patient require write informed consent . The patient receive regimen 15Ôºç30mg/kg valproate sodium give daily oral administration . Pregnant woman , woman breastfeed period woman refuse take contraception measure treatment . Patients poor compliance . Patients blood transfusion therapy .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>valproate sodium</keyword>
	<keyword>metabolic enzyme</keyword>
	<keyword>adverse effect</keyword>
	<keyword>systemic adverse effect</keyword>
</DOC>